Viewing Study NCT05472467


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
Study NCT ID: NCT05472467
Status: UNKNOWN
Last Update Posted: 2022-07-25
First Post: 2022-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer
Sponsor: Sichuan Cancer Hospital and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module